vindesine has been researched along with Leukemia, Myeloid, Acute in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschfeld, S; Ho, PT; Pazdur, R; Smith, M | 1 |
| Asou, N; Emi, N; Honda, S; Kishimoto, Y; Matsuda, S; Matsushima, T; Mitani, K; Miyawaki, S; Miyazaki, Y; Ogawa, Y; Ohno, R; Ohtake, S; Sakamaki, H; Takahashi, M; Yagasaki, F | 1 |
| Hattori, M; Hayashi, Y; Honda, T; Sampi, K | 1 |
| Aoyama, M; Ito, N; Mizoguchi, H; Muto, K; Naohara, T; Okada, M; Oshimi, K; Otani, T; Totsuka, K; Yamada, O | 1 |
| Fassas, A; Kartalis, G; Klearchou, N; Mantalenakis, S; Sinacos, Z; Tsatalas, K | 1 |
| Greenspan, EM; Holland, JF; Ohnuma, T | 1 |
| Carcassonne, Y; Gastaut, JA; Maraninchi, D; Tubiana, N | 1 |
| Mizoguchi, H; Oshimi, K; Totsuka, K | 1 |
| Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
| Bartl, R; Beckert, B; Bock, S; Gieseler, F; Gullis, E; Nerl, C; Nüssler, V; Pelka-Fleischer, R; Petrides, PE; Zwierzina, H | 1 |
| Boogaerts, M; Bosly, A; Carli, MG; Castoldi, G; Cuneo, A; Demuynck, H; Doyen, C; Ferrant, A; Michaux, JL; Piva, N | 1 |
| Gökbuget, N; Hoelzer, D | 1 |
| Furukawa, Y; Kitani, T; Tsukaguchi, M | 1 |
| Kimura, F; Mizukami, H; Motoyoshi, K; Nagata, N; Ohtsuki, T; Takagi, S; Takemura, Y; Yamamoto, K | 1 |
| Auber, ML; Dicke, KA; Horwitz, LJ; Jagannath, S; Spinolo, JA; Spitzer, G; Zander, AR | 1 |
| Bandini, G; Barbui, T; Bassan, R; Battista, R; Ciolli, S; D'Emilio, E; Leoni, F; Rosti, G; Todeschini, G; Zuffa, E | 1 |
| Akagi, K; Asou, N; Goto, J; Hamasaki, N; Hidaka, M; Kawano, F; Kurisaki, H; Sawatari, T; Suzushima, H; Takatsuki, K | 1 |
| Aoki, N; Imai, Y; Murohashi, I; Nara, N; Yamashita, Y | 1 |
| Saito, Y; Uzuka, Y | 1 |
3 review(s) available for vindesine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Approval; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neuroblastoma; Osteosarcoma; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; United States; United States Food and Drug Administration; Vindesine | 2003 |
Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosome Aberrations; Cytarabine; DNA Nucleotidylexotransferase; Etoposide; Female; Gene Rearrangement; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Vindesine | 1993 |
Vindesine in the treatment of leukaemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vindesine | 1997 |
3 trial(s) available for vindesine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult L
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Probability; Remission Induction; Risk Assessment; Treatment Outcome; Vincristine; Vindesine | 2005 |
[Phase II study of Vindesine in patients with hematological malignancy].
Topics: Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Vinblastine; Vindesine | 1983 |
Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Remission Induction; Thioguanine; Vindesine | 1991 |
13 other study(ies) available for vindesine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Two cases of acute myelogenous leukemia with eosinophilia which progressed into complete remission with the treatment mainly consisting of vindesine and prednisolone].
Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Eosinophilia; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Vinblastine; Vindesine | 1983 |
Chemotherapy for acute leukemia during pregnancy. Five case reports.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Vinblastine; Vincristine; Vindesine | 1984 |
Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Infusions, Parenteral; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Vinblastine; Vindesine | 1980 |
[Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Hodgkin Disease; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vinblastine; Vindesine | 1981 |
Vindesine receptors in cells of a human leukaemia cell line.
Topics: Antineoplastic Agents; Cell Line; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Receptors, Drug; Time Factors; Tritium; Vinblastine; Vindesine | 1982 |
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine | 1995 |
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Topics: Adult; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blast Crisis; Bone Marrow Cells; Carrier Proteins; Drug Resistance; Humans; Immunohistochemistry; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Molecular Sequence Data; Monocytes; Myelodysplastic Syndromes; Neoplasm Proteins; Polymerase Chain Reaction; Prednisone; Vindesine | 1994 |
[Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Remission Induction; Vindesine | 1998 |
Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Predictive Value of Tests; Prednisone; Remission Induction; Vindesine | 1992 |
Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1990 |
["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.
Topics: Animals; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Granulocytes; Leukemia, Myeloid, Acute; Macrophages; Mice; Podophyllotoxin; Tumor Stem Cell Assay; Vincristine; Vindesine | 1987 |
Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Vindesine | 1985 |